FARRELL PETER C 4

What Happened

Peter C. Farrell, a director of ResMed Inc. (RMD), disposed of 2,000 shares in an open-market sale on February 4, 2026. The shares were sold at $251.31 per share for aggregate proceeds of $502,620. This was a sale (not a purchase); sales by insiders can be routine and do not necessarily signal a change in outlook.

Key Details

• Transaction date: February 4, 2026
• Price: $251.31 per share; total value: $502,620
• Transaction type: Sale (code S) — open-market/private sale reported
• Filing date (Form 4): February 6, 2026 (Accession: 0000943819-26-000010) — no late-filing flag indicated in the provided excerpt
• Footnote: The sale was made under a Rule 10b5-1 trading plan adopted August 12, 2025 (per footnote F1)
• Shares owned after the transaction: Not specified in the provided filing excerpt

Context

A Rule 10b5-1 plan allows insiders to execute pre-planned trades and is commonly used to avoid trading while in possession of material nonpublic information. Sales executed under such plans are often routine and prearranged rather than reflecting a new, contemporaneous view by the insider. For investors, purchases usually carry more explicit informational weight than scheduled sales; this filing documents a planned disposal by a company director.